Pharmidex will be attending “The 17th Annual BIO CEO & Investor Conference”
February 9, 2015

The BIO CConference is one of the largest investor conference focused on established and emerging publicly traded and select private biotech companies.

Pharmidex will be attending “The 17th Annual BIO CEO & Investor Conference”

Pharmidex will be attending

The BIO CEO & Investor Conference is one of the largest investor conference focused on established and emerging publicly traded and select private biotech companies.


Those attending the conference will have the opportunity to explore a broad variety of industry related investment opportunities. Additionally delegates would have a chance to network with institutional investors, industry analysts & senior biotechnology executives. 


Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities. BIO One-on-One Partnering provides an opportunity to arrange meetings between investors; companies; and industry BD, licensing and therapeutic franchise heads.


The event will be taking place on the 9-10 February 2015, New York City, NY, USA.

March 16, 2026
Pharmidex is proud to be the Networking Sponsor at the Immuno-Oncology & Biomarker Summit in London. Over the next two days, the event provides an opportunity to discuss the latest advances in immuno-oncology, biomarker discovery, and precision medicine. If you’re attending, come and say hello to Ash Alavijeh to connect and explore opportunities to collaborate.
March 13, 2026
We’re excited to announce that Janette Dalay Robertson , Business Development Manager at Pharmidex , will be attending and exhibiting at the 10th RSC-BMCS Symposium on Mastering Medicinal Chemistry on Friday 13 March 2026 at Burlington House, London. Pharmidex is also proud to be sponsoring this fantastic event, which brings together leaders and innovators from across the medicinal chemistry community. If you’re attending, make sure to stop by and speak with Janette at the Pharmidex stand. She will be delighted to connect, discuss your research, and explore how Pharmidex can support your drug discovery and development programmes. 🤝 We look forward to meeting fellow scientists, collaborators, and partners at this exciting meeting.
March 9, 2026
We are pleased to share that Janette Dalay Robertson will be attending Cell & Gene Therapy 2026 taking place 9–10 March 2026 at Hinxton Hall Conference Centre, Cambridge. This event is a fantastic opportunity to connect with leaders across the cell and gene therapy ecosystem and Janette will be there representing Pharmidex and discussing how our scientific services support drug discovery and development. 🤝 Janette would be delighted to meet with fellow attendees to: • Explore new collaborations • Discuss upcoming research programs • Share how Pharmidex can support innovative therapeutic development If you are attending, feel free to reach out and arrange a meeting during the event. We look forward to engaging conversations and building new partnerships within the cell and gene therapy community!
More Posts